Search research articles
Contact Us
Filters
Showing results (41-50 of 119) with videos related to
Page
of 12
Sort By:
Gynecologic Oncology
|
December 17, 2009
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma
John P Diaz, William P Tew, Oliver Zivanovic, et al.
Gynecologic Oncology
|
June 5, 2016
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes
Jill H Tseng, Rudy S Suidan, Oliver Zivanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors
William P Tew, Michael Gordon, John Murren, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
February 26, 2021
Safety and Efficacy of Arterially Directed Liver Therapies in the Treatment of Hepatic Metastatic Ovarian Cancer: A Retrospective Single-Institution Study
Eduardo A Lacayo, Sara Velayati, Ahmed Elsakka, et al.
Cornea
|
November 28, 2021
Refractive Shifts and Changes in Corneal Curvature Associated With Antibody-Drug Conjugates
Julia Canestraro, Malin Hultcrantz, Shanu Modi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Distress in older patients with cancer
Arti Hurria, Daneng Li, Kurt Hansen, et al.
Gynecologic Oncology
|
April 19, 2024
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer
Sarah Ehmann, Clarissa Lam, Qin Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 30, 2013
Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters
Stephanie L Wethington, Yukio Sonoda, Kay J Park, et al.
Cancer
|
October 16, 2013
Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study
William P Tew, Nicoletta Colombo, Isabelle Ray-Coquard, et al.
Gynecologic Oncology
|
March 27, 2012
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
Joyce N Barlin, Fanny Dao, Nadim Bou Zgheib, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 119) with videos related to
Sort By:
Page
of 12
Gynecologic Oncology
|
December 17, 2009
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma
John P Diaz, William P Tew, Oliver Zivanovic, et al.
Gynecologic Oncology
|
June 5, 2016
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes
Jill H Tseng, Rudy S Suidan, Oliver Zivanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors
William P Tew, Michael Gordon, John Murren, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
February 26, 2021
Safety and Efficacy of Arterially Directed Liver Therapies in the Treatment of Hepatic Metastatic Ovarian Cancer: A Retrospective Single-Institution Study
Eduardo A Lacayo, Sara Velayati, Ahmed Elsakka, et al.
Cornea
|
November 28, 2021
Refractive Shifts and Changes in Corneal Curvature Associated With Antibody-Drug Conjugates
Julia Canestraro, Malin Hultcrantz, Shanu Modi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Distress in older patients with cancer
Arti Hurria, Daneng Li, Kurt Hansen, et al.
Gynecologic Oncology
|
April 19, 2024
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer
Sarah Ehmann, Clarissa Lam, Qin Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 30, 2013
Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters
Stephanie L Wethington, Yukio Sonoda, Kay J Park, et al.
Cancer
|
October 16, 2013
Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study
William P Tew, Nicoletta Colombo, Isabelle Ray-Coquard, et al.
Gynecologic Oncology
|
March 27, 2012
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
Joyce N Barlin, Fanny Dao, Nadim Bou Zgheib, et al.
Page
of 12